Urgent.News

What's breaking now, across thousands of outlets.

World

Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition

GLP-1s are very effective at managing diabetes, obesity and weight-related conditions. But they can come with side effects, including nutritional deficiencies.

GLP-1 medications like Ozempic and Mounjaro have helped a large number of Australians manage diabetes, obesity, and weight-related conditions. However, these drugs can cause side effects, including nutritional deficiencies due to decreased food intake. GLP-1s work by mimicking the action of natural gut hormones, affecting appetite, digestion, blood sugar regulation, and metabolism.

Users can expect to lose weight, with semaglutide leading to an average loss of 6.24 kilograms compared to placebo, while tirzepatide can result in a loss of up to 10.8 kilograms. Common side effects include nausea, diarrhoea, vomiting, and indigestion, with less common issues like reflux, gallstones, and pancreatitis. To manage these side effects, individuals should discuss potential issues with their doctor, who may suggest dietary tips or alternative medications.

Maintaining a balanced diet rich in protein, fibre, vitamins, and minerals is crucial, and keeping a food diary can help monitor nutrient intakes to prevent deficiencies, which may range from thiamine and magnesium deficiencies to more severe conditions like metabolic acidosis and heart palpitations.

Written by urgent.news from The Conversation AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at theconversation.com →

More in World

Tanzania Private Investment Push Eyes US$1T

Finance Minister Khamis Mussa Omar and IFC's Ethiopis Tafara agreed in Bangkok to work on private investment for Tanzania's US$1 trillion economy goal. The post Tanzania Private Investment Push Eyes US$1T appeared first on The Rio Times .

More from Tuesday 20 October →